These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35128957)

  • 1. Neprilysin inhibition improves intravenous but not oral glucose-mediated insulin secretion via GLP-1R signaling in mice with
    Esser N; Mongovin SM; Parilla J; Barrow BM; Mundinger TO; Fountaine BS; Larmore MJ; Castillo JJ; Akter R; Hull RL; Zraika S
    Am J Physiol Endocrinol Metab; 2022 Mar; 322(3):E307-E318. PubMed ID: 35128957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Inhibition of Intestinal Neprilysin Enhances Insulin Secretion via GLP-1 Receptor Signaling in Male Mice.
    Esser N; Mundinger TO; Barrow BM; Zraika S
    Endocrinology; 2023 Mar; 164(5):. PubMed ID: 36964914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neprilysin inhibition in mouse islets enhances insulin secretion in a GLP-1 receptor dependent manner.
    Esser N; Barrow BM; Choung E; Shen NJ; Zraika S
    Islets; 2018; 10(5):175-180. PubMed ID: 30142012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulinotropic Effects of Neprilysin and/or Angiotensin Receptor Inhibition in Mice.
    Esser N; Schmidt C; Barrow BM; Cronic L; Hackney DJ; Mongovin SM; Hogan MF; Templin AT; Castillo JJ; Hull RL; Zraika S
    Front Endocrinol (Lausanne); 2022; 13():888867. PubMed ID: 35733766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes.
    Wewer Albrechtsen NJ; Møller A; Martinussen C; Gluud LL; Rashu EB; Richter MM; Plomgaard P; Goetze JP; Kjeldsen S; Hansen LH; Gustafsson F; Deacon CF; Holst JJ; Madsbad S; Bojsen-Møller KN
    Diabetes Obes Metab; 2022 Oct; 24(10):2017-2026. PubMed ID: 35676803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved glycaemia in high-fat-fed neprilysin-deficient mice is associated with reduced DPP-4 activity and increased active GLP-1 levels.
    Willard JR; Barrow BM; Zraika S
    Diabetologia; 2017 Apr; 60(4):701-708. PubMed ID: 27933334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
    Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
    Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a β-Cell Glucagon-Like Peptide 1 Receptor.
    Douros JD; Lewis AG; Smith EP; Niu J; Capozzi M; Wittmann A; Campbell J; Tong J; Wagner C; Mahbod P; Seeley R; D'Alessio DA
    Diabetes; 2018 Aug; 67(8):1504-1511. PubMed ID: 29759973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.
    Lamont BJ; Li Y; Kwan E; Brown TJ; Gaisano H; Drucker DJ
    J Clin Invest; 2012 Jan; 122(1):388-402. PubMed ID: 22182839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-islet glucagon confers β-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon.
    Cabrera O; Ficorilli J; Shaw J; Echeverri F; Schwede F; Chepurny OG; Leech CA; Holz GG
    J Biol Chem; 2022 Feb; 298(2):101484. PubMed ID: 34896391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor.
    Tatarkiewicz K; Sablan EJ; Polizzi CJ; Villescaz C; Parkes DG
    Am J Physiol Regul Integr Comp Physiol; 2014 Apr; 306(7):R490-8. PubMed ID: 24477544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice.
    Liu X; Harada N; Yamane S; Kitajima L; Uchida S; Hamasaki A; Mukai E; Toyoda K; Yamada C; Yamada Y; Seino Y; Inagaki N
    Life Sci; 2009 Jun; 84(25-26):876-81. PubMed ID: 19358859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Cell Glucagon-Like Peptide-1 Receptor Contributes to Improved Glucose Tolerance After Vertical Sleeve Gastrectomy.
    Garibay D; McGavigan AK; Lee SA; Ficorilli JV; Cox AL; Michael MD; Sloop KW; Cummings BP
    Endocrinology; 2016 Sep; 157(9):3405-9. PubMed ID: 27501183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
    Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
    Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles.
    Bueno AB; Showalter AD; Wainscott DB; Stutsman C; Marín A; Ficorilli J; Cabrera O; Willard FS; Sloop KW
    J Biol Chem; 2016 May; 291(20):10700-15. PubMed ID: 26975372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice.
    Wei T; Cui X; Jiang Y; Wang K; Wang D; Li F; Lin X; Gu L; Yang K; Yang J; Hong T; Wei R
    Diabetes; 2023 May; 72(5):599-610. PubMed ID: 36826938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of β cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs.
    Smith EP; An Z; Wagner C; Lewis AG; Cohen EB; Li B; Mahbod P; Sandoval D; Perez-Tilve D; Tamarina N; Philipson LH; Stoffers DA; Seeley RJ; D'Alessio DA
    Cell Metab; 2014 Jun; 19(6):1050-7. PubMed ID: 24836562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice.
    Maida A; Hansotia T; Longuet C; Seino Y; Drucker DJ
    Gastroenterology; 2009 Dec; 137(6):2146-57. PubMed ID: 19766644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice.
    Maida A; Lamont BJ; Cao X; Drucker DJ
    Diabetologia; 2011 Feb; 54(2):339-49. PubMed ID: 20972533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral L-arginine stimulates GLP-1 secretion to improve glucose tolerance in male mice.
    Clemmensen C; Smajilovic S; Smith EP; Woods SC; Bräuner-Osborne H; Seeley RJ; D'Alessio DA; Ryan KK
    Endocrinology; 2013 Nov; 154(11):3978-83. PubMed ID: 23959939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.